Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Debt to Equity (2020 - 2025)

NeuroPace has reported Debt to Equity over the past 6 years, most recently at $3.09 for Q4 2025.

  • Quarterly results put Debt to Equity at $3.09 for Q4 2025, down 58.35% from a year ago — trailing twelve months through Dec 2025 was $3.09 (down 58.35% YoY), and the annual figure for FY2025 was $3.09, down 58.35%.
  • Debt to Equity for Q4 2025 was $3.09 at NeuroPace, down from $3.17 in the prior quarter.
  • Over the last five years, Debt to Equity for NPCE hit a ceiling of $7.43 in Q4 2024 and a floor of -$0.34 in Q1 2021.
  • Median Debt to Equity over the past 5 years was $2.52 (2025), compared with a mean of $2.6.
  • Biggest five-year swings in Debt to Equity: surged 334.79% in 2022 and later tumbled 58.35% in 2025.
  • NeuroPace's Debt to Equity stood at $0.68 in 2021, then surged by 124.36% to $1.52 in 2022, then surged by 81.24% to $2.76 in 2023, then skyrocketed by 169.39% to $7.43 in 2024, then tumbled by 58.35% to $3.09 in 2025.
  • The last three reported values for Debt to Equity were $3.09 (Q4 2025), $3.17 (Q3 2025), and $3.02 (Q2 2025) per Business Quant data.